Filgrastim is approved for several indications, including reduction of the incidence and
duration of chemotherapy-induced neutropenia and for stem cell mobilization. The filgrastim …

Febrile neutropenia (FN) is a common oncologic emergency where quick patient
assessment and prompt initiation of antimicrobial treatment is crucial. Guidelines provide …

Background Data describing the risk factors for the occurrence of severe infections in acute
lymphoblastic leukemia (ALL) patients following induction chemotherapy and the role of …

Purpose This study aimed to establish a population pharmacokinetic (PK) model to evaluate
the dynamic relationship between the concentrations of total and unbound paclitaxel, and …

Background Chemotherapy-induced neutropenia (CIN) is a substantial side effect in
chemotherapy of breast cancer patients. Administration of granulocyte colony stimulating …

Background: Neutropenia and febrile neutropenia (FN) are serious complications of
myelosuppressive chemotherapy and present a considerable burden to patients with …

Aim. To assess the proportion and profile of patients at high risk of febrile neutropenia (FN)
receiving cytotoxic chemotherapy (CT), as well as the incidence of FN and dose-limiting …

To the Editor, We found the article by Heo and colleagues [1] particularly intriguing as the
authors provide valuable insights into the predictive factors for return visits to the emergency …

Reflections on preventable emergency department visits in cancer patients: The role of G-CSF
and telehealth Reflections on preventable emergency department visits in cancer patients …

Аннотация Цель. Оценить долю и профиль пациентов с высоким риском развития
фебрильной нейтропении (ФН), получающих цитотоксическую химиотерапию (ХТ), а …